Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: June 9, 2023

Details for Patent: 7,143,764

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Summary for Patent: 7,143,764
Title:Inhalation device
Abstract:A powder inhaler for administering powder by inhalation which includes: an inhaler body having an opening therein; an inhalation unit disposed in the inhaler body, the inhalation unit including an inhalation channel through which powder is in use inhaled; a dosing unit for providing a dose of powder to the inhalation channel disposed in the inhaler body so as to be rotatable about the central axis thereof, wherein the dosing unit includes a central shaft which is co-axial with the central axis of the inhaler body and has a spiral groove or protrusion on the end face thereof; and an indicating wheel for providing an indication as to the usage of the inhaler disposed in the inhaler body, the indicating wheel having a toothed periphery for engaging the spiral groove or protrusion on the shaft and being disposed such that at least a part thereof is visible through the opening and so as to be rotatable within a diametrical plane containing the central axis of the inhaler body. One side surface of the indicating wheel includes at least one indication which is representative of the usage of the inhaler. In addition, the inhaler body includes a recess in which the opening is provided. The opening allows at least a part of the one side surface of the indicating wheel to be viewed.
Inventor(s): Dagsland; Allan (Karlshamn, SE), Virtanen; Risto (Nurmijarvi, FI)
Assignee: AstraZeneca AB (Sodertalje, SE)
Application Number:09/068,374
Patent Claim Types:
see list of patent claims

Drugs Protected by US Patent 7,143,764

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.